{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T04:34:00Z","timestamp":1789101240286,"version":"build-2803163510"},"reference-count":16,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T00:00:00Z","timestamp":1577145600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.clinthera.2019.12.010","type":"journal-article","created":{"date-parts":[[2020,1,11]],"date-time":"2020-01-11T16:27:19Z","timestamp":1578760039000},"page":"276-285","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Pharmacokinetic, Pharmacodynamic, and Safety Profiles of Ferric Carboxymaltose in Chinese Patients with Iron-deficiency Anemia"],"prefix":"10.1016","volume":"42","author":[{"given":"Yanhua","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxue","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingrui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Palmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Roubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2019.12.010_bib1","series-title":"Iron Deficiency Anaemia: Assessment, Prevention and Control","author":"World Health Organization","year":"2001"},{"key":"10.1016\/j.clinthera.2019.12.010_bib2","doi-asserted-by":"crossref","first-page":"739","DOI":"10.2165\/00003495-200969060-00007","article-title":"Ferric carboxymaltose: a review of its use in iron-deficiency anaemia","volume":"69","author":"Lyseng-Williamson","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.clinthera.2019.12.010_bib3","first-page":"613","article-title":"Iron deficiency and iron deficiency anemia","volume":"53","author":"Ganzoni","year":"1977","journal-title":"ZFA (Stuttgart)"},{"key":"10.1016\/j.clinthera.2019.12.010_bib4","series-title":"Internal Medicine","author":"Lu","year":"2013"},{"key":"10.1016\/j.clinthera.2019.12.010_bib5","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1017\/S1368980008002401","article-title":"Worldwide prevalence of anaemia, WHO vitamin and mineral nutrition information system, 1993-2005","volume":"12","author":"McLean","year":"2009","journal-title":"Public Health Nutr"},{"key":"10.1016\/j.clinthera.2019.12.010_bib6","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1136\/gut.2010.228874","article-title":"Guidelines for the management of iron deficiency anaemia","volume":"60","author":"Goddard","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.clinthera.2019.12.010_bib7","first-page":"345","article-title":"The new generation of intravenous iron: chemistry, pharmacology, and toxicology of ferric carboxymaltose","volume":"60","author":"Funk","year":"2010","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.clinthera.2019.12.010_bib8","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1177\/0091270004268128","article-title":"Differences in drug pharmacokinetics between East Asians and Caucasians and the role of genetic polymorphisms","volume":"44","author":"Kim","year":"2004","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2019.12.010_bib9","first-page":"362","article-title":"Pharmacokinetics, safety and tolerability of intravenous ferric carboxymaltose: a dose-escalation study in volunteers with mild iron-deficiency anaemia","volume":"60","author":"Geisser","year":"2010","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.clinthera.2019.12.010_bib10","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s12185-018-2400-z","article-title":"Pharmacokinetics, pharmacodynamics, safety, and tolerability of intravenous ferric carboxymaltose: a dose-escalation study in Japanese volunteers with iron-deficiency anemia","volume":"107","author":"Ikuta","year":"2018","journal-title":"Int J Hematol"},{"key":"10.1016\/j.clinthera.2019.12.010_bib11","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1159\/000087212","article-title":"Pharmacokinetic study of ferumoxytol: a new iron replacement therapy in normal subjects and hemodialysis patients","volume":"25","author":"Landry","year":"2005","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.clinthera.2019.12.010_bib12","first-page":"43","article-title":"Pharmacokinetics of iron isomaltoside 1000 in patients with inflammatory bowel disease","volume":"6","author":"Nordfjeld","year":"2012","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.clinthera.2019.12.010_bib13","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/clpt.2010.80","article-title":"Plasma pharmacokinetics of two consecutive doses of ferumoxytol in healthy subjects","volume":"88","author":"Pai","year":"2010","journal-title":"Clin Pharmacol Ther"},{"issue":"suppl 2","key":"10.1016\/j.clinthera.2019.12.010_bib14","first-page":"S93","article-title":"Structure, chemistry, and pharmacokinetics of intravenous iron agents","volume":"15","author":"Danielson","year":"2004","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.clinthera.2019.12.010_bib15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/bcpt.13219","article-title":"Pharmacokinetics of ferric bepectate\u2014a new intravenous iron drug for treating iron deficiency","volume":"125","author":"Mu\u00f1oz","year":"2019","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.clinthera.2019.12.010_bib16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/pharmaceutics3010012","article-title":"The pharmacokinetics and pharmacodynamics of iron preparations","volume":"3","author":"Geisser","year":"2011","journal-title":"Phamaceutics"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291819305946?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291819305946?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:52:08Z","timestamp":1758963128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291819305946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0149291819305946"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2019.12.010","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetic, Pharmacodynamic, and Safety Profiles of Ferric Carboxymaltose in Chinese Patients with Iron-deficiency Anemia","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2019.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}